Abbott Laboratories Stock

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 16:00:01 2024-06-18 EDT 5-day change 1st Jan Change
104 USD +0.52% Intraday chart for Abbott Laboratories -0.37% -5.52%
Sales 2024 * 41.72B 57.18B Sales 2025 * 44.73B 61.31B Capitalization 181B 248B
Net income 2024 * 5.98B 8.2B Net income 2025 * 7.17B 9.82B EV / Sales 2024 * 4.47 x
Net Debt 2024 * 5.47B 7.5B Net Debt 2025 * 112M 154M EV / Sales 2025 * 4.05 x
P/E ratio 2024 *
30.1 x
P/E ratio 2025 *
25.9 x
Employees 114,000
Yield 2024 *
2.1%
Yield 2025 *
2.26%
Free-Float 86.96%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.52%
1 week-0.37%
Current month+1.76%
1 month-0.10%
3 months-8.10%
6 months-4.09%
Current year-5.52%
More quotes
1 week
102.43
Extreme 102.43
104.09
1 month
100.64
Extreme 100.64
108.98
Current year
100.64
Extreme 100.64
121.64
1 year
89.67
Extreme 89.674
121.64
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 14-12-31
Director of Finance/CFO 51 96-12-31
Chief Tech/Sci/R&D Officer - 89-12-31
Members of the board TitleAgeSince
Director/Board Member 69 17-02-15
Director/Board Member 63 17-06-28
Director/Board Member 65 11-12-08
More insiders
Date Price Change Volume
24-06-18 104 +0.52% 4,500,985
24-06-17 103.4 -0.22% 3,936,410
24-06-14 103.7 +0.22% 3,682,033
24-06-13 103.4 -0.89% 4,719,494
24-06-12 104.4 -1.35% 4,569,029

Delayed Quote Nyse, June 18, 2024 at 04:00 pm

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104 USD
Average target price
125.4 USD
Spread / Average Target
+20.56%
Consensus